A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation

Clinical trial NCT00150241 · COMPLETED

Trial details

NCT number: NCT00150241
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2000-02-01
Enrollment: 625

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.